Recipients

Entos Pharmaceuticals Inc.

14 agreements worth $88,806,102.07 from 3 departments and 4 programs. Recipient type as recorded: For-profit organizations. Location as recorded: Edmonton, AB; Edmonton, Alberta.

Also recorded as: ENTOS PHARMACEUTICALS INC.; Entos Pharmaceuticals Inc.

Explore every agreement
Total agreement value
$88.8M
$88,806,102.07
Agreements
14
Programs
4
distinct program names
Departments and agencies
3

By fiscal year

By department or agency

Largest agreements

14 of 14
#AgreementValue
1
Innovation and Biomanufacturing Centre project
Edmonton, AB
SIF Stream2- Growth · Innovation, Science and Economic Development Canada · Other transfer payment, starts 2025-02-13
Government record 033-2024-2025-Q4-819748 · data
$62.0M
$62,000,000
2
COVID-19 Vaccine: Phase 1 clinical trial of DNA-based vaccine Covigenix VAX-001
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2020-09-01
Government record 172-2020-2021-Q2-956891 · data
$10.0M
$10,000,000
originally $5.0M
3
COVID-19 Vaccine: Phase 3 Clinical Trial of DNA-Based Vaccine Booster Covigenix VAX-001-1c
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2022-09-01
Government record 172-2022-2023-Q4-1000363 · data
$10.0M
$10,000,000
4
COVID-19 Vaccine: Phase 2 clinical trial of DNA-based vaccine Covigenix VAX-001
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2021-11-01
Government record 172-2021-2022-Q3-981653 · data
$5.2M
$5,200,000
5
Development of an Inhaled Genetic Medicine for Pre-Exposure Prophylaxis of H5N1 Influenza
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2025-11-03
Government record 172-2025-2026-Q3-1037546 · data
$764K
$764,000
6
In Vivo Validation of Fusogenix Formulations Optimized for Delivery of Genetic Medicines to the Trabecular Meshwork of the Eye
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2025-04-01
Government record 172-2025-2026-Q1-1029894 · data
$250K
$250,000
7
UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2025-08-01
Government record 172-2025-2026-Q2-1034236 · data
$131K
$130,700
8
Towards Single-Step manufacturing of LNP Gene Therapy
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2018-10-01
Government record 172-2018-2019-Q3-913718 · data
$129K
$128,600
9
COVID-19 Response: Rapid Prototyping and Deployment of a Fusogenix Vaccine and Immuno-therapeutic against COVID-19
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2020-05-01
Government record 172-2020-2021-Q1-949210 · data
$100K
$100,000
10
(no title in the record)
Edmonton, Alberta
(no program name in the record) · National Research Council Canada · Contribution, starts 2016-10-05
Government record GC-2016-Q3-30611 · data
$96K
$96,000
11
MNC Collab - FOCUS2024 - Fusogenix Formulation Development for Safe and Potent Delivery of Nucleic Acid Cargoes in the Eye
Edmonton, AB
Industrial Research Assistance Program – Contributions to Firms · National Research Council Canada · Contribution, starts 2024-11-01
Government record 172-2024-2025-Q3-1024027 · data
$75K
$75,000
12
(no title in the record)
Edmonton, Alberta
(no program name in the record) · National Research Council Canada · Contribution, starts 2017-11-01
Government record GC-2017-Q3-32853 · data
$27K
$27,000
13
(no title in the record)
Edmonton, Alberta
(no program name in the record) · National Research Council Canada · Contribution, starts 2017-12-07
Government record GC-2017-Q4-33140 · data
$27K
$27,000
14
CIIP PDA – Entos Pharmaceuticals Inc. – 2023-24
Edmonton, AB
Canadian International Innovation Program (CIIP) · Global Affairs Canada · Contribution, starts 2023-10-07
Government record 064-2023-2024-Q3-00038 · data
$8K
$7,802.07

By program

publicly
Canada's Grants Ledger is part of Publicly: sites built from government and court records, with every fact linked to its source. Publicly is not affiliated with any government. Visits are counted with Google Analytics, which sets cookies.